Martin E. Rottenberg
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Response to comments for: Dysregulated IFN-γ, IL-6 and TNF-α after COVID-19 is suggestive of lowered innate immune responses to SARS-CoV-2 and MTB.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: January 09, 2026
Pharmacological inhibition of USP18 improves antibacterial responses and the intracellular control of Mycobacterium tuberculosis in macrophages.
Journal: Frontiers in immunology
Published: November 04, 2025
Latent tuberculosis infection in high TB disease burden countries dysregulates cellular and immunological profiles which is further enhanced with uncontrolled hyperglycemia.
Journal: Scientific reports
Published: September 13, 2025
Dysregulated IFN-γ, IL-6 and TNF-α after COVID-19 is suggestive of lowered innate immune responses to SARS-CoV-2 and MTB.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: August 05, 2025
Individuals with latent tuberculosis in a high TB endemic country show mild COVID-19.
Journal: PloS one
Published: May 09, 2025
Purinergic signaling modulates CD4+ T cells with cytotoxic potential during Trypanosoma cruzi infection.
Journal: The Journal of clinical investigation
Published: September 18, 2024
Immune mapping of human tuberculosis and sarcoidosis lung granulomas.
Journal: Frontiers in immunology
Published: November 03, 2023
Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates.
Journal: Frontiers in immunology
Published: June 24, 2023
Publisher Correction: HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection.
Journal: Nature communications
Published: November 02, 2022
Last Updated: 09/26/2026